(Q82650817)
Statements
Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin (English)
Adam J Foley-Comer
Anne-Marie Young
Fiona Russell-Yarde
29 November 2010